GET DAILY SIGNALSWhy Is agilon health (AGL) Stock Down -3.45% Today?
Key Takeaways
- AGL shares fell 3.45% in Thursday's session, pulling back from the prior day's closing price of $113.77 to roughly $109.84.
- The decline follows an earnings-driven surge of more than 18% in the previous session, making the move largely a bout of profit-taking.
- A broad market selloff—led by technology and AI-related names—weighed on risk appetite and pressured healthcare stocks across the board.
- The stock now trades above the roughly $102–$116 average analyst price target, raising valuation sensitivity after a fivefold run this year.
- Traders are watching whether the post-earnings rally holds and how Medicare Advantage and ACO membership trends develop into 2027.
- Explore Price Targets, Earnings, and Forecast pages for deeper data on AGL.
- To discover AI-driven trading strategies across thousands of tickers, visit Trending AI Robots.
Opening Summary
AGL, the ticker for agilon health, inc., a value-based primary care company that partners with physician groups to serve Medicare patients, traded lower on Thursday. Shares fell 3.45%, declining from a prior close of $113.77 to approximately $109.84 in intraday trading. The pullback comes one day after the stock jumped more than 18% on a better-than-expected third-quarter earnings report, and it unfolded alongside a sharp downturn in the broader market that pressured healthcare and other risk assets.
Profit-Taking After an Earnings Surge
The most immediate driver behind the decline is profit-taking following a powerful earnings-driven rally. On November 4, agilon health reported third-quarter results that exceeded expectations, including revenue of roughly $1.52 billion, a swing to positive adjusted EBITDA of about $64 million versus a loss a year earlier, and a substantial raise to full-year 2026 guidance. Investors responded by sending shares up more than 18% in the following session, with the stock touching an intraday high above $126 before settling at $113.77.
After such a sharp one-day move, it is common for shares to give back a portion of the gains as short-term traders lock in profits and momentum fades. Thursday's modest decline of about 3.45% leaves the stock still well above its pre-earnings level near $96, underscoring that the pullback is a consolidation rather than a reversal of the earnings narrative.
Broad Market Selloff Weighs on Sentiment
The stock's retreat also coincided with a risk-off session across equity markets, driven by a technology- and AI-led rout that pushed major indices lower. When the broader tape turns sharply negative, even stocks with company-specific positive news can face selling pressure as investors reduce exposure and raise cash. Medicare Advantage and value-based care names were among the healthcare groups caught in the downdraft, contributing to AGL's decline despite the constructive fundamental backdrop.
Valuation Sensitivity After a Fivefold Run
The pullback also reflects heightened sensitivity to valuation. AGL has surged roughly fivefold since the start of the year, and it now trades near or above the average analyst price target, which sits in the low-to-mid $100s. With the stock having already priced in much of the operational improvement, investors are more likely to take profits on any sign of market weakness. At the same time, some analysts raised targets following the results, reflecting a more constructive long-term view of the company's value-based care model.
Market Context and Trading Activity
Trading activity has been elevated in recent sessions. The prior day's earnings-driven move occurred on volume well above the stock's three-month average, signaling strong institutional participation. Thursday's session saw continued active trading as investors repositioned after the surge. The decline diverged from the company's own earnings momentum, instead tracking the weakness in the broader healthcare and technology sectors, which suggests the move was more sentiment-driven than a reaction to new company-specific news.
What Comes Next for AGL
Looking ahead, investors will focus on the sustainability of agilon health's improved medical cost trends and margin performance. Management guided for 40–50% ACO membership growth in 2027, even as Medicare Advantage membership declined 10% year over year due to previously announced market exits. The company expects full-year 2027 guidance in February, which will provide the next major catalyst. Risks include the seasonality of medical margins, which management expects to soften sequentially in the fourth quarter, and the broader path of healthcare utilization and cost trends. The company's ability to sustain profitability while expanding its value-based care footprint remains central to the stock's next move.
Trending AI Robots
Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are showcased in the curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving investors a range of automated approaches to explore. To see which strategies are leading the market right now, visit Trending AI Robots.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Aroon Indicator for AGL shows an upward move is likely
AGL's Aroon Indicator triggered a bullish signal on November 06, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 183 similar instances where the Aroon Indicator showed a similar pattern. In 156 of the 183 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on AGL as a result. In 66 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for AGL just turned positive on November 04, 2026. Looking at past instances where AGL's MACD turned positive, the stock continued to rise in 35 of 45 cases over the following month. The odds of a continued upward trend are 78%.
AGL moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AGL crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +29.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where AGL advanced for three days, in 229 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
AGL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.368) is normal, around the industry mean (204.220). P/E Ratio (-8.013) is within average values for comparable stocks, (21.249). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (0.253) is also within normal values, averaging (2.688).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AGL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry HospitalNursingManagement
Advertisement